Generac's Kyle Andrew Raabe sells 598 shares at $210

The Home Power Gen. president's option grant has graded vesting, with exercisability varying by vesting tranche.

Available on EDGAR 11/04/2026 - 04:03 PM EST Accepted by SEC EDGAR 11/04/2026 - 04:02 PM EST

(Neutral)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Kyle Andrew Raabe, President, Home Power Gen. at Generac Holdings Inc. (GNRC), exercised options for 212 shares at an exercise price of $102.4150 per share on November 3, 2026, and sold 598 common shares at $210.0000 per share that day, including the 212 exercise shares. The reported post-transaction option position was 212 shares. The transactions were under a Rule 10b5-1 plan adopted May 5, 2026. The option grant has a graded vesting schedule, with exercisability varying by tranche.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider Raabe Kyle Andrew

Role President, Home Power Gen.

Sold 598 shs ($126K)

Approx. gross sale proceeds $126K

Approx. exercise cost $22K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) ^F3	212	$0.00	$0.00
Sale	Common Stock ^{F1, F2}	386	$210.00	$81K
Exercise	Common Stock ^F1	212	$102.415	$22K
Sale	Common Stock ^F1	212	$210.00	$45K

Holdings After Transaction: Stock Option (Right to Buy) — 212 contracts (Direct); Common Stock — 9,580 shares (Direct)

Footnotes (3)

F1. Adoption date of referenced 10b5-1(c) plan is: 05-05-2026
F2. Multiple lots for the same price for this order have been combined.
F3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

Key Figures

Common shares sold: 598 shares Sale price: $210.0000 per share Shares acquired through option exercise: 212 shares +2 more

5 metrics

Common shares sold 598 shares November 3, 2026

Sale price $210.0000 per share Both reported common-stock sales on November 3, 2026

Shares acquired through option exercise 212 shares November 3, 2026

Option exercise price $102.4150 per share November 3, 2026

Post-transaction option position 212 shares Reported following the November 3, 2026 transaction

Key Terms

Rule 10b5-1(c) plan, graded vesting schedule, Stock Option (Right to Buy)

3 terms

Rule 10b5-1(c) plan regulatory

"adoption date of referenced 10b5-1(c) plan"

graded vesting schedule financial

"Grant has a graded vesting schedule"

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GNRC shares did Kyle Andrew Raabe sell, and at what price?

Kyle Andrew Raabe reported selling 598 common shares at $210.0000 per share on November 3, 2026, in two transactions of 386 shares and 212 shares.

How many GNRC shares did Raabe acquire through option exercise, and at what price?

He exercised options for 212 common shares at an exercise price of $102.4150 per share on November 3, 2026. The reported post-transaction option position was 212 shares.

Were Raabe's GNRC transactions under a Rule 10b5-1 plan?

The reported transactions were under a Rule 10b5-1 plan adopted May 5, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Raabe Kyle Andrew

(Last)

(First)

(Middle)

S45 W29290 HWY.59

C/O GENERAC HOLDINGS INC.

(Street)

WAUKESHA

WISCONSIN

53189

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENERAC HOLDINGS INC. [ GNRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, Home Power Gen.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/03/2026		S⁽¹⁾⁽²⁾		386	D	$210	9,580	D
Common Stock	11/03/2026		M⁽¹⁾		212	A	$102.415	9,792	D
Common Stock	11/03/2026		S⁽¹⁾		212	D	$210	9,580	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$102.415	11/03/2026		M			212	⁽³⁾	03/01/2030	Common Stock	212	$0	212	D

Explanation of Responses:

1. Adoption date of referenced 10b5-1(c) plan is: 05-05-2026

2. Multiple lots for the same price for this order have been combined.

3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

	/s/ Raj Kanuru, Attorney in Fact	11/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR